Next-Generation Sequencing Data Analysis Market is Estimated to Expand at a CAGR of 16.6% during the Forecast Period, observes TMR Report

The latest research study released by Transparency Market Research on "𝐍𝐞𝐱𝐭-𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐒𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠 𝐃𝐚𝐭𝐚 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟐-𝟐𝟎𝟑𝟐 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Next-Generation Sequencing Data Analysis industry, as well as predicted future growth, technological advancements, investment prospects, market economics, and financial data.

Next-Generation Sequencing Data Analysis market is estimated to attain a valuation of US$ 5.4 Bn by the end of 2032, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 16.6% during the forecast period, 2022-2032

𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭-https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85230

𝐇𝐨𝐰 𝐧𝐞𝐱𝐭-𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐬𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠 𝐡𝐚𝐬 𝐞𝐦𝐞𝐫𝐠𝐞𝐝 𝐚𝐬 𝐚 𝐩𝐨𝐰𝐞𝐫𝐟𝐮𝐥 𝐭𝐨𝐨𝐥 𝐟𝐨𝐫 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬?

Humans are exposed to a growing number of infectious diseases that are merely unrecognized. Changes in climatic conditions, settlements near livestock habitats, and the growing population associated with immunocompromised people contribute to the spread of new infections. For these purposes, next-generation sequencing has proved as a suitable choice for the diagnosis of complex diseases. NGS methods have transformed clinical diagnosis with the personalized treatment of several diseases and escalating demand for data solutions which has resulted in boosting R&D activities.

Apart from the rising use of NGS in oncology, NGS is been implemented in the diagnosis of autism and connective tissue disorders. With the advent of NGS technology, researchers are able to compare large stretches of DNA in a cost-effective manner. Such effectiveness widens the scope for other disease diagnostics and therapies.

The Undiagnosed Diseases Program (UDN), under the initiative of NHGRI, is using DNA sequencing to find out the causes of rare diseases. While The Cancer Genome Atlas project under the collaboration of the National Cancer Institute and NHGRI is using DNA sequencing to study the genomic patterns of 30 cancer types. Ongoing initiatives and planned projects in genome sequencing are expected to drive the market.

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐛𝐞𝐟𝐨𝐫𝐞 𝐩𝐮𝐫𝐜𝐡𝐚𝐬𝐞 - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=85230

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥-𝐰𝐢𝐬𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬

𝐇𝐨𝐰 𝐡𝐚𝐬 𝐭𝐡𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 𝐢𝐧 𝐧𝐞𝐱𝐭-𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐬𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠 𝐝𝐚𝐭𝐚 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐢𝐧𝐟𝐥𝐮𝐞𝐧𝐜𝐞𝐝 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝐄𝐮𝐫𝐨𝐩𝐞?

Government initiatives in genome sequencing projects to research rare diseases and virus is propelling the growth of Next-Generation Sequencing Data Analysis in Europe. For instance, European Centre for Disease Prevention and Control launched EpiPulse in 2021, to provide seamless access to data collection and analysis of infectious disease in a single platform. European countries such as Germany, Estonia, the Netherlands and Slovenia have already initiated the development of genomic medicine in their healthcare systems. Moreover, the "2025 France Genomic Medicine Initiative, launched by the government will enable routine genome sequencing and will benefit patients with personalized diagnostics and therapeutic care. Such initiatives will propel the demand for NGS technology in forthcoming years.

𝐓𝐡𝐞 𝐬𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐭 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐍𝐞𝐱𝐭-𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐒𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠 𝐃𝐚𝐭𝐚 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞

Thermo Fisher Scientific, Inc., Qiagen, Illumina, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., PierianDx, Precigen Bioinformatics Germany GmbH, , Eurofins Scientific, Genuity Science, DNAnexus Inc., SciGenom Labs Pvt. Ltd., Golden Helix, Inc., Verily Life Science

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 -

𝐁𝐲 𝐑𝐞𝐚𝐝 𝐋𝐞𝐧𝐠𝐭𝐡:

Long Read Sequencing
Short Read Sequencing
Very Long Read Sequencing

𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐓𝐲𝐩𝐞:

Services
NGS Commercial Software

𝐁𝐲 𝐖𝐨𝐫𝐤𝐟𝐥𝐨𝐰:

Secondary
Tertiary
Primary

𝐁𝐲 𝐒𝐨𝐮𝐫𝐜𝐢𝐧𝐠 𝐓𝐲𝐩𝐞:

Outsourced
In-house

𝐇𝐚𝐯𝐞 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲? 𝐀𝐬𝐤 𝐓𝐨 𝐀𝐧𝐚𝐥𝐲𝐬𝐭: https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=85230

𝐒𝐨𝐦𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐫𝐞𝐜𝐞𝐧𝐭 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 𝐛𝐲 𝐤𝐞𝐲 𝐩𝐫𝐨𝐯𝐢𝐝𝐞𝐫𝐬 𝐨𝐟 𝐍𝐞𝐱𝐭-𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐒𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠 𝐃𝐚𝐭𝐚 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐫𝐞 𝐚𝐬 𝐟𝐨𝐥𝐥𝐨𝐰𝐬:

In May 2022, Illumina, Inc and Allegheny Health Network (AHN) declared the collaboration for in-house comprehensive genomic profiling. The collaboration will assess tissue and blood samples, and will aim to ensure whether the approach will assist cancer patients.

In January 2022, Illumina undertook co-development partnership with SomaLogic to bring SomaScan Proteomics Assay to Illumina's next -generation sequencing platforms. It is aimed to spur throughput sector of the proteomic market. Researchers will be able to make more out of biological connections from genetic sequence to cellular function.

In October 2021, Verogen Inc., partnered with Cellmark Forensics Services to provide new sequencing technology which is aimed to supplement current specialist DNA capabilities. Verogen's ForenSeq DNA signature Prep kit resolves forensic investigations and complex relationship cases, and ensures advanced phenotypic insights for the forensic services.

In November 2019, Thermo Fisher Scientific unveiled Ion Torrent Genexus System, its first fully integrated, next-generation sequencing platform involving an automated specimen which is able to deliver results in a single day. The new paradigm is aimed at making the hospitals adopt NGS technique in future.

In February 2019, Agilant Technologies, launched new next generation sequencing library system primarily built to run complex DNA with just a click of button. New reagents and protocols present in the new system makes it suitable to assay multiple genes and complex genetic aberrations from genomic DNA.

𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐥𝐞𝐭𝐬 𝐲𝐨𝐮 𝐢𝐝𝐞𝐧𝐭𝐢𝐟𝐲 𝐭𝐡𝐞 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐍𝐞𝐱𝐭-𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐒𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠 𝐃𝐚𝐭𝐚 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐦𝐞𝐚𝐧𝐬 𝐨𝐟 𝐚 𝐫𝐞𝐠𝐢𝐨𝐧:

North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
South America (Brazil etc.) The Middle East and Africa (North Africa and GCC Countries)

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 -

𝐖𝐚𝐭𝐞𝐫 𝐏𝐮𝐫𝐢𝐟𝐢𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2022/07/21/2483639/0/en/Water-Purifier-Market-is-estimated-to-Develop-at-a-CAGR-of-10-5-during-the-Forecast-Period-notes-TMR-Study.html

𝐂𝐚𝐩𝐬𝐢𝐜𝐮𝐦 𝐎𝐥𝐞𝐨𝐫𝐞𝐬𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2022/07/21/2483763/0/en/Capsicum-Oleoresin-Market-is-Estimated-to-Expand-at-a-CAGR-of-7-9-during-the-Forecast-Period-observes-TMR-Report.html

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬

Nikhil Sawlani

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

This release was published on openPR.